Constantino F. R.
- Country
- Spain
- Department
- Nephrology department, As Xubias 84, PC 15006. A Coruña, Spain
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Efficacy of Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Randomized Controlled Multicenter Study
- Evaluation of Reduced Immunosuppression Regimen with Tacrolimus, Prednisolone, and Mycophenolate Sodium in Older Adult Kidney Transplant Recipients with End-Stage Renal Disease
Data & Insights
Has run more than one trial at 10 of 63 partner sites.
Specializations
Transplant Medicine
This investigator specializes in kidney transplantation with particular emphasis on managing post-transplant complications. Their research focuses on developing therapeutic strategies for antibody-mediated rejection in transplant recipients.
- Chronic Rejection Management
- Graft Function Preservation
- Immunosuppression Optimization
Key interest lies in evaluating novel therapeutic approaches for maintaining long-term kidney allograft survival.
Nephrology
The investigator concentrates on monitoring and improving renal function in transplant patients, with specific attention to glomerular filtration rate assessment and preservation.
- Kidney Function Assessment
- Clinical Biomarkers
- Renal Protection Strategies
Expertise includes long-term monitoring of kidney transplant outcomes and graft function markers.
Immunology
Research interests encompass transplant immunology with focus on understanding and treating immune-mediated rejection mechanisms in kidney transplant recipients.
- Antibody-Mediated Rejection
- Immunological Response
- Novel Immunotherapy Approaches
Specialized in evaluating innovative therapeutic interventions for managing chronic rejection conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.